Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.47 |
| ▸ | PTPRA | P18433 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.42 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | FPR2 | P25090 | 1/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.37 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.37 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KDM6B | O15054 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9554662 | 1.00 | TBXAS1 (0.47) | TBXAS1PTPRATAAR1FDPSSMN1; SMN2 | |
| SCHEMBL11456188 | 0.83 | TBXAS1 (0.49) | TBXAS1TAAR1FDPSSMN1; SMN2GAA | |
| Histidine SCHEMBL27753697 | 0.80 | GRIA1 (0.39) | TBXAS1PTPRASMN1; SMN2ALOX15GRIA1 | |
| SCHEMBL5185101 | 0.80 | TBXAS1 (0.46) | TBXAS1TAAR1FDPSSMN1; SMN2GAA | |
| SCHEMBL7511041 | 0.80 | TBXAS1 (0.46) | TBXAS1TAAR1FDPSSMN1; SMN2GAA | |
| SCHEMBL24834446 | 0.80 | GRIA2 (0.51) | TBXAS1TAAR1FDPSALOX15FPR2 | |
| SCHEMBL3838965 | 0.80 | GRIA2 (0.51) | TBXAS1TAAR1FDPSALOX15FPR2 | |
| SCHEMBL781663 | 0.80 | GRIA2 (0.51) | TBXAS1TAAR1FDPSALOX15FPR2 | |
| SCHEMBL31544487 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL11090438 | 0.77 | GRIA1 (0.49) | TBXAS1TAAR1FDPSALOX15FPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20230204605-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2023-06-29 | — | — | US | claimed |
| EP-2820038-B1 | GLP-1 PRODRUGS | NOVO NORDISK AS (DK) | 2020-06-17 | — | — | EP | claimed |
| EP-3043810-B1 | IMMUNE SYSTEM MODULATORS | CANIMGUIDE THERAPEUTICS AB (SE) | 2019-10-23 | — | — | EP | claimed |
| EP-3141284-B1 | METHOD OF STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE | OREAL (FR) | 2019-08-28 | — | — | EP | claimed |
| CN-104185639-B | Prodrug of G L P-1 | 诺和诺德股份有限公司 | 2018-06-19 | — | — | CN | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |
| EP-1991574-B1 | OXYNTOMODULIN DERIVATIVES | MERCK SHARP & DOHME (US) | 2016-10-12 | — | — | EP | claimed |
| EP-2029237-B1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE | ORÉAL L (FR) | 2016-10-12 | — | — | EP | claimed |
| CN-102389413-A | Composition for treating diabetes and application thereof | WANG QINGHUA (CA) | 2012-03-28 | — | — | CN | claimed |
| US-20110183902-A1 | PHARMACEUTICAL COMPOSITION COMPRISING OXYNTOMODULIN DERIVATIVES AND A METHOD FOR REDUCING BODY WEIGHT USING THE COMPOSITION | MERCK SHARP & DOHME CORP. (US) | 2011-07-28 | — | — | US | claimed |
| US-20110111066-A1 | METHOD AND COMPOSITION FOR IMPROVED ANABOLISM | BIO-ENGINEERED SUPPLEMENTS AND NUTRITION, INC. (US) | 2011-05-12 | — | — | US | claimed |
| EP-2305785-A1 | Use of a carboxylic or amino compound as cleaning aid for hard surfaces and method of cleaning such hard surfaces | Unilever N.V. (NL) | 2011-04-06 | — | — | EP | claimed |
| US-20100300471-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE | L'OREAL S.A. (FR) | 2010-12-02 | — | — | US | claimed |
| US-20100166675-A1 | Pharmaceutical Composition for the Treatment of Type 1-Diabetes | Wang, Qinghua (CA) | 2010-07-01 | — | — | US | claimed |
| US-20100144617-A1 | Oxyntomodulin Derivatives | MERCK SHARP & DOHME LLC | 2010-06-10 | — | — | US | claimed |
| CN-101389648-A | Oxyntomodulin derivatives | MERCK & CO INC ANGELETTI P IST (US) | 2009-03-18 | — | — | CN | claimed |
| EP-1991574-A2 | OXYNTOMODULIN DERIVATIVES | Merck & Co., Inc. (US) | 2008-11-19 | — | — | EP | claimed |
| WO-2007100535-A2 | OXYNTOMODULIN DERIVATIVES | MERCK & CO., INC. (US) | 2007-09-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100300471-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE | KRT18, KLK5, HOGA1 | TBXAS1 4009/4885PTPRA 4676/4885TAAR1 4102/4885 |
| US-20100166675-A1 | Pharmaceutical Composition for the Treatment of Type 1-Diabetes | IAPP, GABRB1, GLP1R | TBXAS1 3008/4885PTPRA 2893/4885TAAR1 1706/4885 |
| US-20100144617-A1 | Oxyntomodulin Derivatives | GPR119, OGFRL1, OGFR | TBXAS1 1163/4885PTPRA 2512/4885TAAR1 710/4885 |
| US-20110183902-A1 | PHARMACEUTICAL COMPOSITION COMPRISING OXYNTOMODULIN DERIVATIVES AND A METHOD FOR REDUCING BODY WEIGHT USING THE COMPOSITION | OGFR, GPR119, THOP1 | TBXAS1 2288/4885PTPRA 2932/4885TAAR1 1064/4885 |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | GLS, AADAT, FGF23 | TBXAS1 4757/4885PTPRA 3259/4885TAAR1 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.